Study Bias Likely Explains Link Between Antacid Therapy and Reduced Mortality in IPF, Research Suggests

The introduction of bias in the design and analysis of studies likely explains a reported reduction of mortality with antacid therapy in patients with idiopathic pulmonary fibrosis (IPF), according to a new Canadian review study. The research, “The effect of anti-acid therapy on survival in idiopathic…